Press Releases

Date	Title	Company
23-May-2023	AI based software for crystallization studies	Technobis Crystallization Systems
23-May-2023	Vicore obtains significant new patent protection for C21 in the US	Vicore Pharma Holding AB
23-May-2023	Scarlet Therapeutics Announces Seed Financing to Advance Development of Therapeutic Red Blood Cell Platform	Scarlet Therapeutics
23-May-2023	Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology	Valo Therapeutics
23-May-2023	New SmiLe company Suturion plans to launch its surgical sewing machine this year	Suturion
23-May-2023	AnaMar Announces Positive Phase I Data for its Phase II Ready Compound AM1476 for Treating Fibrosis	AnaMar
23-May-2023	Qlucore's software for cancer diagnostics on its way to obtaining CE certification	Qlucore
23-May-2023	FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients	XBiotech
23-May-2023	YARAL PHARMA PARTNERS WITH EVERSANA TO SUPPORT THE COMMERCIALIZATION OF ITS EXPANDING GENERICS PORTFOLIO	EVERSANA
23-May-2023	Orgenesis Academy graduates first class of cell and gene therapy experts from theraCell Laboratories-backed master’s program	Orgenesis
23-May-2023	Molecular glues to tackle ‘undruggable’ disease targets	Francis Crick Institute
23-May-2023	PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases	PharmEnable
23-May-2023	BioSenic provides first quarter 2023 business update	BioSenic
23-May-2023	ABPI response to DHSC antimicrobial resistance research funding	ABPI
23-May-2023	Promising Phase 1 results for antibody NI006 in ATTR cardiomyopathy published in The New England Journal of Medicine	Neurimmune
23-May-2023	Two thirds of Brits would take part in a clinical trial to help discover new treatments - but financial payment is key	Lindus Health
23-May-2023	Europe Pelvic Floor Diagnostics Market is set to rise at a 7.8% CAGR \| Exclusive Report by FMI	MARKITWIRED
23-May-2023	Pelvic Floor Stimulators Market is estimated to grow at a CAGR of 8.8% during the forecast period ending in 2031	MARKITWIRED
23-May-2023	Ocular Drug Delivery System Market sales will total US$ 27.82 Billion by 2031 \| Says Future Market Insights	MARKITWIRED
23-May-2023	Necrotizing Fasciitis Treatment Market value worth US$ 4.6 Billion is projected for the industry by 2032 \| FMI	MARKITWIRED